Oxcarbazepine
Product Images NDC 0615-8567

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 0615-8567). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oxcarbazepinetabstruct (Oxcarbazepine Tabs 150 mg 300 mg 8447 8448 1)

Oxcarbazepinetabstruct (Oxcarbazepine Tabs 150 mg 300 mg 8447 8448 1)
Chemical structure of the active ingredient in Oxcarbazepine 150 mg/1, showing a dibenzazepine ring system with keto and amide functional groups.*
FDA Label Image

Oxcarbazepinetabfig1 (Oxcarbazepine Tabs 150 mg 300 mg 8447 8448 2)

Oxcarbazepinetabfig1 (Oxcarbazepine Tabs 150 mg 300 mg 8447 8448 2)
A Kaplan-Meier curve showing exit rates over time from day 2 to day 11 in a clinical trial. The solid line represents the Oxcarbazepine treatment group, and the dashed line represents the placebo group. The graph includes a log-rank test p-value of 0.0001 indicating statistical comparison between groups.*
FDA Label Image

Oxcarbazepinetabfig2 (Oxcarbazepine Tabs 150 mg 300 mg 8447 8448 3)

Oxcarbazepinetabfig2 (Oxcarbazepine Tabs 150 mg 300 mg 8447 8448 3)
A Kaplan-Meier plot depicting seizure rate over days from first dose to first seizure, comparing Oxcarbazepine treatment group (solid line) versus placebo group (dashed line). The y-axis shows seizure rate from 0 to 1, and the x-axis shows time in days up to 140. A log-rank test p-value of 0.046 is noted, indicating statistical analysis between the two groups.*
FDA Label Image

Oxcarbazepinetabfig3 (Oxcarbazepine Tabs 150 mg 300 mg 8447 8448 4)

Oxcarbazepinetabfig3 (Oxcarbazepine Tabs 150 mg 300 mg 8447 8448 4)
A Kaplan-Meier plot depicting exit rate over time in days for two treatment groups labeled HIGH (solid line) and LOW (dashed line). The exit rate progresses along the y-axis from 0 to 1, with time to exit shown on the x-axis up to 130 days. The chart includes a log-rank test p-value of 0.0001, indicating statistical comparison between groups.*
FDA Label Image

Oxcarbazepinetabfig4 (Oxcarbazepine Tabs 150 mg 300 mg 8447 8448 5)

Oxcarbazepinetabfig4 (Oxcarbazepine Tabs 150 mg 300 mg 8447 8448 5)
A Kaplan-Meier survival curve showing exit rate over time (days) for two treatment groups labeled HIGH and LOW. The solid line represents the HIGH group and the dotted line the LOW group. A log-rank test p-value of 0.0001 is noted, indicating a statistically significant difference between groups.*
FDA Label Image

Oxcarbazipinetabcamberlogo1 (Oxcarbazepine Tabs 150 mg 300 mg 8447 8448 6)

FDA Label Image

Oxcarbazipinetabcamberlogo2 (Oxcarbazepine Tabs 150 mg 300 mg 8447 8448 7)

FDA Label Image

Principal Display Panel 150 mg (Oxcarbazepine Tabs 150 mg 300 mg 8447 8448 8)

Principal Display Panel 150 mg (Oxcarbazepine Tabs 150 mg 300 mg 8447 8448 8)
Packaging label for Oxcarbazepine Tablets USP 150 mg from NCS HealthCare of KY, LLC dba Vangard Labs. The label displays the proprietary name Oxcarbazepine, strength 150 mg tablets, lot number, expiration date placeholder, quantity of 30 tablets, and barcodes. The package is marked for institutional use only and includes storage instructions at controlled room temperature. Manufactured by Annora for Camber and packaged by Vangard in Glasgow, KY.*
FDA Label Image

Principal Display Panel 300 mg (Oxcarbazepine Tabs 150 mg 300 mg 8447 8448 9)

Principal Display Panel 300 mg (Oxcarbazepine Tabs 150 mg 300 mg 8447 8448 9)
This label is for Oxcarbazepine Tablets USP 300 mg, manufactured by Annora for Camber and packaged by Vangard Labs in Glasgow, KY. The label includes lot and expiration date placeholders, a barcode, and space for recording received dates. It states storage instructions at 20°-25°C and indicates the product is for institutional use only. The quantity indicated is 30 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.